Literature DB >> 11307174

Hemoglobin variants and determination of glycated hemoglobin (HbA1c).

W J Schnedl1, A Liebminger, R E Roller, R W Lipp, G J Krejs.   

Abstract

Measurement of glycated hemoglobin in diabetic patients is an established procedure for evaluating long-term control of diabetes. The Diabetes Control and Complications Trial (DCCT), as well as the United Kingdom Prospective Diabetes Study (UKPDS), confirmed the direct relationship between the degree of glycemic control as estimated by glycohemoglobin (GHb) determinations and the development and progression of long-term complications in diabetic patients. Samples with known interferences of HbA(1c) determination as hemoglobinopathies are specifically excluded from certification testing and there are no guidelines or requirements for comparability of samples containing hemoglobin (Hb) variants. This paper reviews the interference of Hb variants on determination methods of glycated hemoglobin as they result in false HbA(1c) results.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11307174     DOI： 10.1002/dmrr.186

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN： 1520-7552            Impact factor:   4.876


  9 in total

1.  Lack of precision in HbA(1c) values on variant II in cases of hemoglobin Q India.

Authors:  P K Nigam; S Sharma; R Sareen; V Paul; A Lal
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  Immobilization of aminophenylboronic acid on magnetic beads for the direct determination of glycoproteins by matrix assisted laser desorption ionization mass spectrometry.

Authors:  Jeong Heon Lee; Yangsun Kim; Mi Young Ha; Eun Kyu Lee; Jaebum Choo
Journal:  J Am Soc Mass Spectrom       Date:  2005-09       Impact factor: 3.109

3.  Conditions associated with very low values of glycohaemoglobin measured by an HPLC method.

Authors:  J L Camargo; J L Gross
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

4.  Silent haemoglobin variants and determination of HbA(1c) with the HPLC Bio-Rad Variant II.

Authors:  T Lahousen; R E Roller; R W Lipp; W J Schnedl
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

5.  Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.

Authors:  M Kato; M Noda; H Suga; T Nakamura; M Matsumoto; Y Kanazawa
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

6.  Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study.

Authors:  Masayuki Kato; Yoshihiko Takahashi; Yumi Matsushita; Tetsuya Mizoue; Manami Inoue; Takashi Kadowaki; Shoichiro Tsugane; Mitsuhiko Noda
Journal:  J Diabetes Investig       Date:  2011-10-07       Impact factor: 4.232

7.  Hb A1c Separation by High Performance Liquid Chromatography in Hemoglobinopathies.

Authors:  Vani Chandrashekar
Journal:  Scientifica (Cairo)       Date:  2016-02-16

8.  Hemoglobin Providence (β82 Lys > Asn, Asp) and lower-than-expected HbA1c in a nonadherent teenager with type 1 diabetes: a case report and literature review.

Authors:  Charles N Newman; Christine M Litwin; Deborah A Bowlby; Katherine A Lewis; Remberto C Paulo
Journal:  Clin Case Rep       Date:  2017-10-30

9.  Misleading HbA1c Measurement in Diabetic Patients with Hemoglobin Variants.

Authors:  Manthana Mitchai; Nattakarn Suwansaksri; Suphakdee Seanseeha; Jindamanee Saenboonsiri; Putthichai Kraitree; Jirasak Piyapromdee; Atit Silsirivanit
Journal:  Med Sci (Basel)       Date:  2021-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.